openPR Logo
Press release

Percutaneous Endoscopic Gastrostomy (PEG) Kit Market Size, Sales, Average Price and Trends Analysis, till 2032

05-13-2025 12:59 PM CET | Health & Medicine

Press release from: Datavagyanik Business Intelligence

Percutaneous Endoscopic Gastrostomy (PEG) Kit Market Size,

Percutaneous Endoscopic Gastrostomy (PEG) Kit Market Size is estimated to be $650million in 2024 and is expected to grow at an average yearly rate of around 7% during the timeframe (2025-2032).

Monitor Country-wise Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales and Demand with Our Comprehensive Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales Database

Gain in-depth insights into the Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales landscape across 20+ countries with our specialized Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales Database. Stay ahead in the market by tracking country-wise Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales, identifying key manufacturers.

Extensive Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales database covering 20+ countries worldwide, Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales trends

Percutaneous Endoscopic Gastrostomy (PEG) Kit market revenue tracker by country

Stay Updated with Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales Trends

Track real-time Percutaneous Endoscopic Gastrostomy (PEG) Kit prices, analyze Percutaneous Endoscopic Gastrostomy (PEG) Kit price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Percutaneous Endoscopic Gastrostomy (PEG) Kit Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/percutaneous-endoscopic-gastrostomy-peg-kit-market/



Percutaneous Endoscopic Gastrostomy (PEG) Kit sales trend in 2024 vs 2025

The sales trend of Percutaneous Endoscopic Gastrostomy (PEG) kits has seen notable shifts between 2024 and 2025, shaped by evolving healthcare demands, technological advancements, and demographic changes. PEG kits, which are vital for patients who require long-term nutritional support due to swallowing difficulties or chronic illnesses, continue to gain prominence across the global healthcare landscape.

Market Behavior in 2024

In 2024, PEG kit sales witnessed strong growth, primarily driven by increasing medical awareness and a surge in the elderly population. Hospitals and long-term care facilities reported higher demand for enteral feeding solutions, especially for patients suffering from neurological disorders such as stroke, Parkinson's disease, or dementia. These conditions often impair the ability to swallow, necessitating alternative feeding methods like PEG.

Another contributing factor was the rise in cancer cases, particularly head, neck, and esophageal cancers, where patients frequently require PEG tubes to maintain adequate nutrition during treatment. Additionally, the post-COVID healthcare environment emphasized home-based care and non-invasive procedures, further boosting PEG kit adoption. Sales figures showed a steady increase throughout the year, and many manufacturers scaled up production to meet growing global demand.

Technological innovation also played a crucial role. Companies introduced PEG kits with enhanced safety features, ease of insertion, and reduced risk of infection. These developments made the procedure more acceptable among healthcare professionals and patients, which led to broader adoption in both developed and emerging markets.

Growth Trajectory in 2025

Moving into 2025, PEG kit sales are projected to grow at an even faster pace. The increasing recognition of PEG as a cost-effective and minimally invasive method of long-term feeding is encouraging more hospitals and clinics to adopt it as a standard practice. Moreover, the rising prevalence of chronic lifestyle diseases like diabetes and obesity has indirectly contributed to complications requiring PEG intervention.

A key trend emerging in 2025 is the expansion of PEG kit usage beyond traditional hospital settings. More patients are being managed at home or in outpatient care, prompting a demand for kits designed for home use, with simplified instructions and user-friendly designs. This shift reflects a broader trend in healthcare toward decentralization and patient-centered care.

Emerging markets are also playing a greater role in the 2025 landscape. Countries in Asia, Latin America, and parts of Africa are investing in healthcare infrastructure, which is increasing access to specialized procedures like PEG. As training and awareness improve, these regions are expected to contribute significantly to global PEG kit sales.

Request for customization https://datavagyanik.com/reports/percutaneous-endoscopic-gastrostomy-peg-kit-market/



Percutaneous Endoscopic Gastrostomy (PEG) Kit Market Definition

The Percutaneous Endoscopic Gastrostomy (PEG) kit market refers to the global industry focused on the production, distribution, and utilization of medical kits used in the PEG procedure-a minimally invasive method of providing nutrition to patients who are unable to consume food orally. These kits are essential components in modern enteral feeding systems, particularly in long-term care and critical care settings.

What is a PEG Kit?

A PEG kit includes all the necessary tools required to perform a PEG procedure. This medical technique involves inserting a flexible feeding tube through the abdominal wall directly into the stomach, guided by an endoscope. The procedure is generally used for patients who cannot swallow or ingest food due to medical conditions such as neurological disorders, cancer, or gastrointestinal diseases.

Each PEG kit typically includes a feeding tube, introducer needle, guidewire, dilators, and fixation devices. These components are sterile and designed for single-use, ensuring patient safety and reducing the risk of infection. PEG kits are used by trained medical professionals in hospitals, outpatient facilities, and increasingly, in home healthcare settings.

Scope of the Market

The PEG kit market spans across a broad spectrum of healthcare systems, encompassing both developed and developing countries. It includes various stakeholders such as manufacturers, healthcare providers, distributors, and regulatory agencies. The demand for PEG kits is driven by several factors, including the increasing global burden of chronic diseases, an aging population, advancements in medical procedures, and growing awareness of enteral nutrition options.

PEG kits are commonly used in:

Hospitals (for inpatient care and surgeries)

Nursing homes and long-term care centers

Home healthcare (for patients discharged with ongoing feeding requirements)

Specialized outpatient clinics

Market Segmentation

The market can be segmented based on several criteria:

Product Type: Kits may vary by tube size, material (such as silicone or polyurethane), or design features that enhance patient comfort and reduce complications.

Application: PEG kits are used for conditions including cancer, neurological disorders, digestive system diseases, and trauma.

End User: Hospitals, ambulatory surgical centers, and home care settings form key user segments.

Geography: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa are key regions where PEG kits are distributed and used.

Market Trends and Growth Drivers

The PEG kit market is undergoing continuous evolution, driven by innovation and growing healthcare needs. Trends such as the shift toward home-based care, rising awareness of enteral nutrition, and improvements in minimally invasive technologies are pushing the market forward. Additionally, government healthcare initiatives and insurance coverage in many regions are making PEG procedures more accessible.



Important target segments driving the demand for Percutaneous Endoscopic Gastrostomy (PEG) Kit Market

The demand for Percutaneous Endoscopic Gastrostomy (PEG) kits is increasing steadily due to growing healthcare needs worldwide. These kits are essential in providing long-term nutritional support to patients who are unable to consume food orally. Several target segments across different demographics and medical conditions are driving this demand, shaping the market's growth and direction. Understanding these segments is crucial for manufacturers, healthcare providers, and policymakers aiming to meet the rising needs of modern enteral feeding practices.

1. Geriatric Population

One of the most significant contributors to the rising demand for PEG kits is the aging population. Elderly individuals are more prone to chronic diseases such as stroke, dementia, Parkinson's disease, and other neurological or swallowing disorders that compromise their ability to eat normally. PEG kits offer a safe and efficient method of nutritional delivery for this group, ensuring they receive adequate sustenance without the risks associated with traditional feeding methods. As global life expectancy continues to rise, so too does the reliance on PEG procedures in elder care.

2. Patients with Neurological Disorders

Patients suffering from neurological conditions represent another key target segment. Disorders such as ALS (amyotrophic lateral sclerosis), multiple sclerosis, cerebral palsy, and traumatic brain injuries often result in impaired swallowing ability. For these patients, PEG tubes provide a lifeline, delivering nutrition directly to the stomach. As the diagnosis rate of neurological diseases increases and survival rates improve due to medical advances, the number of patients requiring long-term nutritional management also grows, further expanding the PEG kit market.

3. Cancer Patients

Individuals undergoing treatment for head, neck, esophageal, and gastrointestinal cancers frequently experience difficulty eating due to the effects of surgery, radiation, or chemotherapy. PEG kits allow for consistent and comfortable nutritional intake, supporting their recovery and overall health during treatment. This segment represents a particularly high-value target due to the critical nature of maintaining adequate nutrition during cancer therapy. The rising global incidence of cancer continues to fuel demand in this area.

4. Pediatric Patients with Congenital Conditions

Children born with congenital abnormalities that affect swallowing, digestion, or neuromuscular function often require PEG feeding. Though smaller in volume compared to adult segments, the pediatric group is an important and growing market. Improvements in neonatal and pediatric care have increased the survival rate of children with complex conditions, creating sustained demand for PEG kits tailored to their specific needs.

5. Home Healthcare and Long-Term Care Facilities

The shift from hospital-based to home-based care has created a surge in demand for PEG kits that are easy to use outside traditional clinical settings. Patients discharged from hospitals but still requiring enteral feeding often continue their nutritional support at home or in long-term care centers. This segment emphasizes the need for kits with user-friendly designs and detailed usage instructions, promoting safe application by caregivers and family members.


Key Players in Percutaneous Endoscopic Gastrostomy (PEG) Kit, Market Share

The Percutaneous Endoscopic Gastrostomy (PEG) kit market is a vital component of the global medical devices industry, catering to the needs of patients requiring long-term nutritional support through enteral feeding. The market has grown significantly due to increasing cases of chronic illnesses, aging populations, and a rising focus on minimally invasive procedures. A handful of major players dominate this market, with their combined influence shaping the industry landscape.

Major Companies Driving the Market

Several key players have emerged as leaders in the PEG kit market, distinguished by their product innovation, global reach, and focus on quality and patient safety.

1. Fresenius Kabi

Fresenius Kabi is one of the largest and most influential companies in the PEG kit market. Known for its focus on clinical nutrition and infusion therapy, the company offers a wide range of enteral feeding solutions. Its global distribution network and reputation for high-quality medical products give it a strong competitive edge, making it a top choice among healthcare institutions.

2. Cardinal Health

Cardinal Health is a major name in the healthcare and medical supply industry. Its comprehensive product lines, including PEG kits, serve hospitals and clinics across the globe. Cardinal's established logistics infrastructure and wide customer base help maintain its prominent market position.

3. Avanos Medical

Specializing in medical devices for chronic and acute care, Avanos Medical is a recognized brand in the enteral feeding sector. The company has developed advanced PEG kits that improve safety and ease of use, making it a preferred provider for both hospital and home care settings.

4. Boston Scientific

Boston Scientific brings its endoscopic expertise to the PEG kit market. The company's deep involvement in minimally invasive procedures and its reputation for technological innovation have helped it gain traction among healthcare providers focused on advanced patient care.

5. Nestlé Health Science

Nestlé Health Science, a division of the global nutrition giant, leverages its expertise in medical nutrition to offer high-quality PEG kits. While primarily known for nutritional products, its strategic integration with feeding device technologies allows it to serve a broader healthcare audience.

6. Applied Medical Technology (AMT)

AMT is a specialist in enteral feeding devices, including low-profile and balloon-style PEG tubes. Its focus on comfort and long-term usability, particularly for pediatric and long-term care patients, makes it a valuable player in the market.

7. Cook Medical

Cook Medical provides a range of medical devices, including solutions for gastrointestinal procedures. Its PEG kits are designed for ease of use and patient safety, contributing to its steady presence in the market.

Market Share Overview

The PEG kit market is moderately concentrated, with the top 8 to 10 companies accounting for around 70% of the global market share. This dominance is largely due to the high regulatory standards and technical expertise required to manufacture PEG kits. Larger companies benefit from economies of scale, established supply chains, and strong brand trust, allowing them to command a majority share of the market.

Key Questions Answered in the Percutaneous Endoscopic Gastrostomy (PEG) Kit market report:

What is the total global Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales volume, and how has it changed over the past five years?

What is Percutaneous Endoscopic Gastrostomy (PEG) Kit price trend, what has been the historical prices?

What will be the Percutaneous Endoscopic Gastrostomy (PEG) Kit price trend in 2025?

Which countries have the highest Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales, and what factors contribute to their dominance in the market?

How does Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales vary across key manufacturers, and what expansions have been observed recently?

What is the current global revenue generated from Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales, and how does it compare to previous years?

Which industries drive the highest demand for Percutaneous Endoscopic Gastrostomy (PEG) Kit, and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Percutaneous Endoscopic Gastrostomy (PEG) Kit Sales and market dynamics?

Related Studies:

Breast Surgery Localization Wires Market
https://datavagyanik.com/reports/breast-surgery-localization-wires-market/

Lumbar Catheters Market
https://datavagyanik.com/reports/lumbar-catheters-market-size-production-sales-average-product-price-market-share-import-vs-export/

Minimally invasive Intracranial Drainage Systems Market
https://datavagyanik.com/reports/minimally-invasive-intracranial-drainage-systems-market/

Retrievable inferior vena cava (IVC) filters Market
https://datavagyanik.com/reports/retrievable-inferior-vena-cava-ivc-filters-market/

Coronary Atherectomy Devices Market
https://datavagyanik.com/reports/coronary-atherectomy-devices-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/
Email: sales@datavagyanik.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Percutaneous Endoscopic Gastrostomy (PEG) Kit Market Size, Sales, Average Price and Trends Analysis, till 2032 here

News-ID: 4013188 • Views:

More Releases from Datavagyanik Business Intelligence

Beta-Sitosterol Supplements Market Size, Clinical Trials, Product Pipelines and Investment Trends, till 2032
Beta-Sitosterol Supplements Market Size, Clinical Trials, Product Pipelines and …
Beta-Sitosterol Supplements Market Size is estimated to be $670 million in 2024 and is expected to grow at an average yearly rate of around 9% during the timeframe (2025-2032). What is Beta-Sitosterol Supplements and what are the growth drivers of Beta-Sitosterol Supplements Market? Beta-sitosterol is a naturally occurring plant sterol found in fruits, vegetables, nuts, and seeds. Structurally similar to cholesterol, it competes with dietary cholesterol
Cranberry-based Supplements Market Size, Clinical Trials, Product Pipelines and Investment Trends, till 2032
Cranberry-based Supplements Market Size, Clinical Trials, Product Pipelines and …
Cranberry-based Supplements Market Size is estimated to be $1040 million in 2024 and is expected to grow at an average yearly rate of around 8% during the timeframe (2025-2032). What is Cranberry-based Supplements and what are the growth drivers of Cranberry-based Supplements Market? Cranberry-based supplements are dietary products formulated from cranberry fruit-most commonly Vaccinium macrocarpon-available in various forms such as tablets, capsules, powders, and liquid extracts. These supplements either contain
Lipase Inhibitors Market Size, Clinical Trials, Product Pipelines and Investment Trends, till 2032
Lipase Inhibitors Market Size, Clinical Trials, Product Pipelines and Investment …
Lipase Inhibitors Market Size is estimated to be $945 million in 2024 and is expected to grow at an average yearly rate of around 6% during the timeframe (2025-2032). What is Lipase Inhibitors and what are the growth drivers of Lipase Inhibitors Market? Lipase inhibitors are compounds that block the activity of lipase, an enzyme responsible for breaking down dietary fats in the digestive system. By inhibiting lipase, these substances
Tricyclic Antidepressants Market Size, Clinical Trials, Product Pipelines and Investment Trends, till 2032
Tricyclic Antidepressants Market Size, Clinical Trials, Product Pipelines and In …
Tricyclic Antidepressants Market Size is estimated to be $4950 million in 2024 and is expected to grow at an average yearly rate of around 7% during the timeframe (2025-2032). What is Tricyclic Antidepressants and what are the growth drivers of Tricyclic Antidepressants Market? Tricyclic antidepressants (TCAs) are a class of medications primarily used to treat major depressive disorder. They are among the earliest forms of antidepressants

All 5 Releases


More Releases for PEG

Biopharma PEG Delivers Innovative PEG Solutions for Enhanced Drug Efficacy
Watertown, MA - October 24, 2024 - Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in drug development is more critical than ever. PEGylation provides numerous advantages, such as improved solubility, enhanced stability, and increased circulation time in the bloodstream. By
Biopharma PEG Expands Multi-Arm PEG Product Line
Biopharma PEG, a leader in PEG derivatives, is excited to announce the expansion of its high-purity Multi-Arm PEG linker product line, catering to the evolving needs of the medical and bioorganic fields. These advanced PEG linkers are available in various functional groups and molecular weights ranging from 1k to 40k, offering unmatched versatility and performance for research and development in cutting-edge medical applications. "Biopharma PEG is committed to delivering high-purity multi-arm
Biopharma PEG Supplies PEG Products Used For Infectious Disease Vaccines
As of January 1, 2023, global vaccine development includes a total of 966 vaccine candidates, of which 23% (220) are traditional inactivated or attenuated vaccines. Advances in molecular technology have facilitated the development of other platforms, such as recombinant protein vaccines, nucleic acid vaccines, and viral vector vaccines, which have further diversified global vaccine development. Recombinant protein vaccines accounted for the largest proportion of all pipeline in development, 22% (215), due
Biopharma PEG Supplies PEG Products For Click Chemistry Reactions
What is "click chemistry"? "Click Chemistry", this is a literary name given to this kind of reaction by the Nobel Prize winner K.Burry Sharless, when the cards are put together, "click" (click). Simply put, it is to add two structures to two molecules respectively, and these two structures can be specifically combined to synthesize the required chemical molecules. One of the most famous click-chemistry reactions is the Cu-catalyzed azide-alkyne cycloaddition
Biopharma PEG Develops PEG Linkers for Antibody Drug Conjugates
Antibody-drug conjugate (ADC) is one of the fastest growing fields in tumor therapy, which consists of monoclonal antibody (Antibody), linker (Linker) and active drug (Payload). So far, there are only 15 drugs on the market in the world. However, with the development of some perfect antibody modification techniques, advanced site-specific coupling techniques and powerful small-molecule toxins, ADC drug research has mushroomed and a large number of ADC drugs are in
Biopharma PEG Provides Multi-arm PEG Derivatives Crosslinked Into Hydrogels
Polyethylene (ethylene glycol) is a hydrophilic polymer that can have a very high water content when cross-linked into a network. Polyethylene glycol (PEG) is a suitable material for biological applications because it does not normally elicit an immune response. Since the 1970s, PEG has been used to modify therapeutic proteins and peptides in order to increase their solubility, reduce their toxicity, and prolong their cyclic half-lives. In the late 1970s,